VISTAGEN THERAPEUTICS, INC. Deferred Costs
VISTAGEN THERAPEUTICS, INC. (VTGN) had Deferred Costs of $334.30 thousand as of 2021-06-30, per its 10-Q filed 2021-08-12.
Discontinued › Balance Sheet › Assets
us-gaap:DeferredCostsCurrentAndNoncurrent · last filed 2021-08-12
- 2021-06-30: Deferred Costs $334.30K.
- 2021-03-31: Deferred Costs $367.60K.
- 2020-12-31: Deferred Costs $409.10K.
- 2020-09-30: Deferred Costs $438.60K.
| Period end | Deferred Costs |
|---|---|
| 2021-06-30 | $334.30K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $367.60K 10-Q · filed 2021-08-12 |
| 2020-12-31 | $409.10K 10-Q · filed 2021-02-11 |
| 2020-09-30 | $438.60K 10-Q · filed 2020-11-12 |
| 2020-03-31 | $0.00 10-Q · filed 2021-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |